Publications To Date


    Filter Publications

    PAGE 6 OF 19 | DISPLAYING 76 - 90 OF 271 RESULTS

    Rozenblit M et al., Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod., , Sci Rep, Jun 12, 2019

    Stromnes IM et al., Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma, , Cancer Immunol Res., Jun 01, 2019

    Yang W et al., Immune signature profiling identified prognostic factors for gastric cancer., , Chin J Cancer Res, Jun 01, 2019

    Rozeman EA et al., Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial, , Lancet Oncol., May 31, 2019

    Lopez-Bujanda ZA et al., Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression, , bioRxiv, May 28, 2019

    Monteiro AC et al., Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma., , Mol Oncol., May 23, 2019

    Ragulan C et al., Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes., , Sci Rep, May 21, 2019

    Klintman J et al., Differential genomic and transcriptomic events associated with high-grade transformation of Chronic Lymphocytic Leukemia, , bioRxiv, May 21, 2019

    Ndreshkjana B et al., Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells, , Cell Death & Disease, May 16, 2019

    Roelands J et al., Genomic landscape of tumor-host interactions with differential prognostic and predictive connotations, , bioRxiv, May 08, 2019

    Waks AG et al., The immune microenvironment in hormone receptor-positive breast cancer before and after preoperative chemotherapy., , Clin Cancer Res. , May 06, 2019

    Vázquez-Arreguín K et al., Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy, , PLoS Genet., May 06, 2019

    Allen CT et al., Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis, , J Immunother Cancer, May 03, 2019

    Perez-Ruiz E et al., Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy, , Nature, May 01, 2019

    Maguire A et al., Enhanced DNA repair and genomic stability identify a novel HIV related Diffuse Large B‐cell Lymphoma signature, , Int J Cancer., May 01, 2019